欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
BIBR 1532_321674-73-1_产品详情
321674-73-1
  • names:

    BIBR 1532

  • CAS号:

    321674-73-1

    MDL Number:
  • MF(分子式): C21H17NO3 MW(分子量): 331.36
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
BIBR 1532
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
YZM001275-50mg 50mg 99.94% ¥ 4394.25 ¥ 4394.25 2-3天
- +
¥ 0.00
YZM001275-10mg 10mg 99.94% ¥ 1088.10 ¥ 1088.10 2-3天
- +
¥ 0.00
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名
英文别名
CAS号 321674-73-1
Inchi
InchiKey
分子式 Formula C21H17NO3
分子量 Molecular Weight 331.36
溶解度Solubility 生物体外In Vitro:DMSO溶解度≥ 100 mg/mL(301.79 mM)*"≥" means soluble可溶, but saturation unknown溶解度未知.
性状
储藏条件 Storage conditions 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月
BIBR 1532(CAS:321674-73-1)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
产品说明 BIBR 1532 是一种有效的,选择性的telomerase非竞争性抑制剂,IC50值为 100 nM
IntroductionBIBR 1532 is a potent, selective and nonompetitivetelomeraseinhibitor withIC50of 100 nM in a cellree assay.
Application1
Application2
Application3
BIBR 1532 是一种有效的,选择性的telomerase非竞争性抑制剂,IC50值为 100 nM。BIBR 1532 is a potent, selective and non-competitivetelomeraseinhibitor withIC50of 100 nM in a cell-free assay.
警示图
危险性
危险性警示
安全声明
安全防护
备注
【1】.Pascolo E, et al. Mechanism of human telomerase inhibition by BIBR1532, a synthetic, non-nucleosidic drug candidate. J Biol Chem. 2002 May 3;277(18):15566-72.
【2】.El-Daly H, et al. Selective cytotoxicity and telomere damage in leukemia cells using the telomerase inhibitor BIBR1532. Blood. 2005 Feb 15;105(4):1742-9.
【3】.Ward RJ, et al. Pharmacological telomerase inhibition can sensitize drug-resistant and drug-sensitive cells to chemotherapeutic treatment. Mol Pharmacol. 2005 Sep;68(3):779-86.
【4】.Rth A, et al. Short telomeres and high telomerase activity in T-cell prolymphocytic leukemia. Leukemia. 2007 Dec;21(12):2456-62.
【5】.Meng E, et al. Targeted inhibition of telomerase activity combined with chemotherapy demonstrates synergy in eliminating ovarian cancer spheroid-forming cells. Gynecol Oncol. 2012 Mar;124(3):598-605.
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents